Researchers: Audrey Bousquet, Keia Sanderson, T Michael O’Shea, Rebecca C Fry
Individuals born preterm have shorter lifespans and elevated rates of chronic illness that contribute to mortality risk when compared to individuals born at term. Emerging evidence suggests that individuals born preterm or of low birthweight also exhibit physiologic and cellular biomarkers of accelerated aging. It is unclear whether, and to what extent, accelerated aging contributes to a higher risk of chronic illness and mortality among individuals born preterm. Here, we review accelerated aging phenotypes in adults born preterm and biological pathways that appear to contribute to accelerated aging. We highlight biomarkers of accelerated aging and various resiliency factors, including both pharmacologic and non-pharmacologic factors, that might buffer the propensity for accelerated aging among individuals born preterm.
References
- The role of lipid metabolism in aging, lifespan regulation, and age-related disease.
- Strategies to Prevent Sarcopenia in the Aging Process: Role of Protein Intake and Exercise.
- The ageing immune system as a potential target of senolytics.
- Biomarkers of aging.
- Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?
- Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
- Metabolic changes in aging humans: current evidence and therapeutic strategies.